“The current medication for Alzheimer’s disease is approved, essentially, because it’s better than nothing,” [British neuroscientist Jeff] Jebelli said last week.
“These drugs were pioneered in the ’70s and ’80s and they treat the symptoms, as opposed to the underlying biology. And we found that in about 60 percent of patients these drugs will delay the symptoms by about six months to a year. And that is certainly better than nothing. … But six months to a year is just simply not good enough.”
The Vanishing Mind
An excellent series of articles from May 2012 in the N.Y. Times regarding the emotional impact of dementia.
A Third of U.S. Seniors Die With Dementia, Study Finds
Statistical article from March 2013 regarding the financial impact of dementia on our society.
Tracking the most recent articles regarding scientific research into dementia.
How to defeat Alzheimer’s
Finding effective treatments could avert a healthcare disaster. But where’s the money?
Pharmaceutical Seeds – Drug development is on the rise in Pittsburgh, but there’s room to grow.